NEUROTROPE
Live / Registered — Registered (as of 07 Jan 2020)
What this means for you
Registered since 07 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88025318
- Registration number
- 5956626
- Mark type
- Design + words
- Filed
- 03 Jul 2018
- Published for opposition
- 02 Jul 2019
- Registered
- 07 Jan 2020
- Attorney of record
- Laura B. Siegal
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research and development services in the field of the development and clinical testing for others of new pharmaceutical preparations, therapeutic agents, and diagnostic detection devices principally for Alzheimer's Disease, neurodegenerative diseases and developmental disorders
Owner
- Neurotrope Bioscience, Inc., New York, NY, US
- Neurotrope Bioscience, Inc., New York, NY, US
- Neurotrope Bioscience, Inc., New York, NY, US
Prosecution history
- 07 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 06 Dec 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Dec 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Nov 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Oct 2019 — USE AMENDMENT FILED
- 13 Nov 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Oct 2019 — TEAS STATEMENT OF USE RECEIVED
- 27 Aug 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Jul 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Jul 2019 — PUBLISHED FOR OPPOSITION
- 12 Jun 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 May 2019 — ASSIGNED TO LIE
- 10 May 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Apr 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED